The use of thrombolytic agents

Compendium: Continuing Education For Veterinarians

Volumn 29, Issue 8, 2007, Pages 476-482

  Whelan, Megan F ^a   O'Toole, Therese E ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ANIMAL; ANIMAL DISEASE; CAT; CAT DISEASE; DOG; DOG DISEASE; PERIPHERAL VASCULAR DISEASE; REVIEW; SAFETY; THROMBOSIS; TREATMENT OUTCOME;

ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; FIBRINOLYTIC AGENTS; PERIPHERAL VASCULAR DISEASES; SAFETY; THROMBOSIS; TREATMENT OUTCOME;

EID: 34548631276     PISSN: 19408307     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Good LI, Manning A: Thromboembolic disease: Physiology of hemostasis and pathophysiology of thrombosis. Compend Contin Educ Pract Vet 25(9):650-675, 2003.
2. Welles EG, Boudreaux MK, Crager CS, et al: Platelet function and antithrombin, plasminogen, and fibrinolytic activities in cats with heart disease. Am J Vet Res 55(5):619-627, 1994.
3. Helenski CA, Ross JN: Platelet aggregation in feline cardiomyopathy. J Vet Intern Med 1(1):24-28, 1987.
4. McMichael MA, Freeman LM, Rozanski EA, et al: Plasma homocysteine, B vitamins, and amino acid concentrations in cats with cardiomyopathy and arterial thromboembolism. J Vet Intern Med 14(5):507-512, 2000.
5. Smith SA, Tobias AH: Feline arterial thromboembolism: An update. Vet Clin North Am Small Anim Pract 34(5):1245-1271, 2004.
6. Van Winkle TJ, Hackner SG, Liu SM: Clinical and pathological features of aortic thromboembolism in 36 dogs. J Vet Emerg Crit Care 3(1):13-21, 1993.
7. Boswood A, Lamb CR, White RN: Aortic and iliac thrombosis in six dogs. J Small Anim Pract 41(3):109-114, 2000.
8. MacGregor JM, Rozanski EA, McCarthy RJ, et al: Cholesterol-based pericardial effusion and aortic thromboembolism in a 9-year-old mixed-breed dog with hypothyroidism. J Vet Intern Med 18(3):354-358, 2004.
9. Santamarina G, Espino L, Vila M, et al: Aortic thromboembolism and retroperitoneal hemorrhage associated with a pheochromocytoma in a dog. J Vet Intern Med 17(6):917-922, 2003.
10. Greco DS, Green RA: Coagulation abnormalities associated with thrombosis in a dog with nephrotic syndrome. Compend Contin Educ Pract Vet 9(6):653-658, 1987.
11. Whelan MF, O'Toole TE, Lipitz L, et al: Aortic thromboembolism in dogs: 21 cases (1999-2004). J Vet Emerg Crit Care 15(3; suppl 1):S8, 2005.
12. Patel SC, Mody A: Cerebral hemorrhagic complications of thrombolytic therapy. Prog Cardiovas Dis 42(3):217-233, 1999.
13. Vanscoy GJ, Rihn TL, Koerner PH: Tenecteplase: Innovative fibrinolysis for ST-segment elevation myocardial infarction (STEMI). Pharm Ther 28(1):20-30, 2003.
14. Arcasoy SM, Kreit JW: Thrombolytic therapy of pulmonary embolism. Chest 115(6):1695-1707, 1999.
15. Gladysheva IP, Turner RB, Sazonova IY, et al: Coevolutionary patterns in plasminogen activation. Proc Natl Acad Sci USA 100(16):9168-9172, 2003.
16. Thompson MF, Scott-Moncrieff JC, Hogan DF, et al: Thrombolytic therapy in dogs and cats. J Vet Emerg Crit Care 11(2):111-121, 2001.
17. Lateef F, Anantharaman V: Hypotension in acute myocardial infarction patients given streptokinase. Singapore Med J 41(4):172-176, 2000.
18. Loscalzo J, Braunwald E: Tissue plasminogen activator. N Engl J Med 319(14):925-931, 1988.
19. Longstaff C, Thelwell C: Understanding the enzymology of fibrinolysis and improving thrombolytic therapy. FEBS Lett 579(15):3303-3309, 2005.
20. Abbokinase® package insert. ImaRx Therapeutics, 2006.
21. Zamarron C, Lijnen HR, Van Hoef B, et al: Biological and thrombolytic properties of proenzyme and active forms of human urokinase-I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology. Thromb Haemost 52(1):19-23, 1984.
22. Hariton GB, Findlay JM, Weir BK, et al: Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model. Neurosurgery 33(4):691-697, 1993.
23. Idell S, Mazar A, Cines D, et al: Single-chain urokinase alone or complexed to its receptor in tetracycline-induced pleuritis in rabbits. Am J Respir Crit Care Med 166(7):920-926, 2002.
24. Lijnen HR, De Wreede K, Demarsin E, et al: Biological and thrombolytic properties of proenzyme and active forms of human urokinase-IV. Variability in fibrinolytic response of plasma of several mammalian species. Thromb Haemost 52(1):31-33, 1984.
25. Burke SE, Lubbers NL, Nelson RA, et al: Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model. Thromb Haemost 81(2):301-305, 1999.
26. Badylak SF, Voytik S, Klabunde RE, et al: Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis. Thromb Res 52(4):295-312, 1988.
27. Whitley D, Gloviczki P, Rhee R, et al: Urokinase treatment preserves endothelial and smooth muscle function in experimental acute arterial thrombosis. J Vasc Surg 23(5):851-859, 1996.
28. Lang IM, Marsh JJ, Konopka RG, et al: Factors contributing to increased vascular fibrinolytic activity in mongrel dogs. Circulation 87(6):1990-2000, 1993.
29. Maki A, Shirato C, Ohguchi M, et al: Mechanism of rethrombosis after thrombolytic therapy: Angioscopic findings and investigation of the coagulation system in dogs. Angiology 49(6):447-453, 1998.
30. Wengrovitz M, Healy DA, Gifford RR, et al: Thrombolytic therapy and balloon catheter thrombectomy in experimental femoral artery thrombosis: Effect on arterial wall morphology. J Vasc Interv Radiol 6(2):205-210, 1995.
31. Menon V, Harrington RA, Hochman JS, et al: Thrombolysis and adjunctive therapy in acute myocardial infarction: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(S3):549S-575S, 2004.
32. Califf RM, Fortin DF, Tenaglia AN, et al: Clinical risks of thrombolytic therapy. Am J Cardiol 69(2):12A-20A, 1992.
33. Pion PD, Kittleson MD: Therapy for feline aortic thromboembolism, in Kirk R (ed): Current Veterinary Therapy X. Philadelphia, WB Saunders, 1989, pp 295-302.
34. McMichael M: Ischemia-reperfusion injury: Assessment and treatment, part II. J Vet Emerg Crit Care 14(4):242-252, 2004.
35. Schiffman F, Ducas J, Hollett P, et al: Treatment of canine pulmonary hypertension with recombinant tissue plasminogen activator. Circulation 78(1):214-220, 1988.
36. Whelan MF, O'Toole TE, Chan DL, et al: Retrospective evaluation of urokinase use in dogs with thromboembolism (4 cases: 2003-2004). J Vet Emerg Crit Care 15(3; suppl 1):S8, 2005.
37. Johnson LR, Lappin MR, Baker DC: Pulmonary thromboembolism in 29 dogs: 1985-1995. J Vet Intern Med 13(4):338-345, 1999.
38. Killingsworth CR, Eyster GE, Adams T, et al: Streptokinase treatment of cats with experimentally induced aortic thrombosis. Am J Vet Res 47(6):1351-1359, 1986.
39. Ramsey CC, Riepe RD, Macintire DK, et al: Streptokinase: A practical clotbuster? Proc IVECCS V:225-228, 1996.
40. Moore KE, Morris N, Dhupa N, et al: Retrospective study of streptokinase administration in 46 cats with arterial thromboembolism. J Vet Emerg Crit Care 10(4):245-257, 2000.
41. Kittleson MD: Feline myocardial disease, in Ettinger SJ, Feldman EC (eds): Textbook of Veterinary Internal Medicine. St. Louis, Elsevier Saunders, 2005, pp 1082-1104.
42. th ACVIM:925, 1987.
43. Pion PD: Feline aortic thromboemboli and the potential utility of thrombolytic therapy with tissue plasminogen activator. Vet Clin North Am Small Anim Pract 18(1):79-87, 1988.
44. Whelan MF, O'Toole TE, Chan DL, et al: Retrospective evaluation of urokinase use in cats with arterial thromboembolism. J Vet Emerg Crit Care 15(3; suppl 1):S8, 2005.
45. Smith SA, Tobias AH, Jacob KA, et al: Arterial thromboembolism in cats: Acute crisis in 127 cases (1992-2001) and long-term management with low-dose aspirin in 24 cases. J Vet Intern Med 17(1):73-83, 2003.
46. Schoeman JP: Feline distal aortic thromboembolism: A review of 44 cases (1990-1998). J Feline Med Surg 1(4):221-231, 1999.
47. Ramsey CC, Burney DP, Macintire DK, et al: Use of streptokinase in four dogs with thrombosis. JAVMA 209(4)780-785, 1996.
48. Clare AC, Kraje BJ: Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog. JAVMA 212I4):539-543, 1998.
49. Bliss SP, Bliss SK, Harvey HJ: Use of recombinant tissue-plasminogen activator in a dog with chylothorax secondary to catheter-associated thrombosis of the cranial vena cava. JAAHA 38(5):431-435, 2002.